Suchergebnisse - "Babiker, Hani M"

PubPharm (12)

1

Targeting leukemia inhibitory factor in pancreatic adenocarcinoma

enthalten in: Expert opinion on investigational drugs | 2023

von Wang, J. | Karime, C. | Majeed, U. | +3

2

Clinical complexity of utilizing FGFR inhibitors in cancer therapeutics

enthalten in: Expert opinion on investigational drugs | 2020

von Chandana, S. | Babiker, H. | Mahadevan, D.

3

E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases

enthalten in: Investigational new drugs | 2019

von Babiker, H. | Byron, S. | Hendricks, W. | +20

4

A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials : Challenges and Patient-centric Recommendations

enthalten in: Expert opinion on investigational drugs | 2019

von Babiker, H. | Davis, L. | Larson, K. | +14

5

Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)

enthalten in: Expert opinion on investigational drugs | 2019

von Babiker, H. | Karass, M. | Recio-Boiles, A. | +3

6

Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)

enthalten in: Expert opinion on investigational drugs | 2019

von Chandana, S. | Babiker, H. | Mahadevan, D.

7

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

enthalten in: The New England journal of medicine | 2018

von Migden, M. | Rischin, D. | Schmults, C. | +34

CommentIn: Nat Rev Clin Oncol. 2018 Aug;15(8):472. - PMID 29921845

8

Cardiotoxic effects of chemotherapy : A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system

enthalten in: Critical reviews in oncology/hematology | 2018

von Babiker, H. | McBride, A. | Newton, M. | +7

9

Ublituximab for the treatment of CD20 positive B-cell malignancies

enthalten in: Expert opinion on investigational drugs | 2018

von Babiker, H. | Glode, A. | Cooke, L. | +1

10

Therapeutic potential of investigational CHK-1 inhibitors for the treatment of solid tumors

enthalten in: Expert opinion on investigational drugs | 2017

von Babiker, H. | McBride, A. | Cooke, L. | +1